ME Research UK

Investing in ME Research globally

ME Research UK is focused on funding biomedical research into ME/CFS – to find its cause, develop effective treatments and, ultimately, discover a cure. Approximately 250,000 people in the UK alone are affected by ME/CFS with 25% of those being house- or bed-bound. Research offers hope.

history Campaign has now closed

It ran from 12:00 PM, 30 November 2021 to 12:00 PM, 7 December 2021

Registered Charity in Scotland (SC036942)

open_in_new http://www.meresearch.org.uk/
Check mark Match funded

Campaign target

£7,600

Amount raised

£7,700

Donations

75

Championed by The Hospital Saturday Fund

    Categories

  • Health/WellbeingHealth/Wellbeing
  • Medical ResearchMedical Research

    Helping

  • General Public/HumankindGeneral Public/Humankind
  • People With DisabilitiesPeople With Disabilities

Location

United Kingdom

Situation

ME/CFS is a relatively common illness. The physical symptoms can be as disabling as other neurological illnesses e.g.multiple sclerosis. However, ME/CFS has faced significant under-investment in biomedical research over many years. Whereas MS affects about 100,000 people compared to the 240,000 estimated to have ME/CFS, MS has received 20 times the funding. Together - we can change that and deliver the research which those with ME/CFS deserve.

Solution

ME Research UK funds the work of a growing number of scientists in the UK and worldwide researching ME/CFS and believes that the answers to ME/CFS will be uncovered by biomedical research. Robust, relevant research is what most patients and carers want to see. To achieve this, ME Research UK invests in the most promising research and encourages new researchers with fresh, novel ideas to undertake a career in ME research. To achieve a breakthrough in ME research more research is needed.

  • ME Research UK has provided the pilot funding for many distinct projects, showing what can be achieved by biomedical scientists working closely with medical research charities.

    — Prof. Julia Newton